<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_TU-Eindhoven_Results"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:TU-Eindhoven/Results">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:TU-Eindhoven/Results&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:TU-Eindhoven/Results&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:TU-Eindhoven/Results&amp;action=history">History               </A></LI><LI style="color:white;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:TU-Eindhoven/Results" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:TU-Eindhoven/Results</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2013.igem.org</H3><DIV class="navwrapper"><DIV class="container"><DIV class="navbar"><DIV class="navbar-inner"><UL class="nav"><LI id="tue-menu-home"><A href="/Team:TU-Eindhoven">Home</A></LI><LI id="tue-menu-team"><A href="/Team:TU-Eindhoven/Team">Team</A></LI><LI id="tue-menu-project" class="dropdown"><A class="dropdown-toggle" data-toggle="dropdown" href="#">Project </A></LI><LI><A href="/Team:TU-Eindhoven/Project">Abstract</A></LI><LI><A href="/Team:TU-Eindhoven/Description">Project Description</A></LI><LI><A href="/Team:TU-Eindhoven/Background">Background</A></LI><LI><A href="/Team:TU-Eindhoven/Chasis">The Chassis</A></LI><LI><A href="/Team:TU-Eindhoven/Production">Potential Contrast Agents</A></LI><LI><A href="/Team:TU-Eindhoven/KillingMechanism">Kill Switch</A></LI><LI><A href="/Team:TU-Eindhoven/Applications">Applications</A></LI><LI class="nav-header">Results</LI><LI><A href="/Team:TU-Eindhoven/Results">Main Results</A></LI><LI><A href="/Team:TU-Eindhoven/Parts">Parts Submitted</A></LI><LI class="nav-header">Outlook</LI><LI><A href="/Team:TU-Eindhoven/FutureProspects">Future Steps</A></LI><LI class="nav-header">Others</LI><LI><A href="/Team:TU-Eindhoven/Attributions">Attributions</A></LI><LI><A href="/Team:TU-Eindhoven/Collaboration">Collaboration</A></LI><LI><A href="/Team:TU-Eindhoven/Achievements">Achievements</A></LI></UL><LI id="tue-menu-wetlab" class="dropdown"><A class="dropdown-toggle" data-toggle="dropdown" href="#">Wetlab </A></LI><LI><A href="/Team:TU-Eindhoven/Wetlab">Overview</A></LI><LI><A href="/Team:TU-Eindhoven/Preparation">Preparation</A></LI><LI class="nav-header">Lab Reports</LI><LI><A href="/Team:TU-Eindhoven/MRIProcessing">MRI Data Processing</A></LI><LI><A href="/Team:TU-Eindhoven/AnearobicTesting">Anaerobic FNR Testing</A></LI><LI><A href="/Team:TU-Eindhoven/CESTAgentTesting">CEST Agent Testing</A></LI><LI><A href="/Team:TU-Eindhoven/LabJournal">Lab Journal</A></LI><LI id="tue-menu-drylab" class="dropdown"><A class="dropdown-toggle" data-toggle="dropdown" href="#">Drylab </A></LI><LI><A href="/Team:TU-Eindhoven/Modeling">Summary</A></LI><LI><A href="/Team:TU-Eindhoven/ProteinSelection">Protein Selection</A></LI><LI class="nav-header">Contrast Mechanism</LI><LI><A href="/Team:TU-Eindhoven/StochasticModel">Decoy Sites</A></LI><LI><A href="/Team:TU-Eindhoven/ODEModel">FNR Dynamics</A></LI><LI><A href="/Team:TU-Eindhoven/FNRPromotor">FNR Promotor</A></LI><LI><A href="/Team:TU-Eindhoven/IntegralModel">Integral Model</A></LI><LI class="nav-header">Bacteria in the Body</LI><LI><A href="/Team:TU-Eindhoven/PBPK">Ganciclovir Distribution</A></LI><LI><A href="/Team:TU-Eindhoven/TimeKill">Time-kill Behavior</A></LI><LI id="tue-menu-safety" class="dropdown"><A class="dropdown-toggle" data-toggle="dropdown" href="#">Safety </A></LI><LI><A href="/Team:TU-Eindhoven/Safety">Overview</A></LI><LI><A href="/Team:TU-Eindhoven/LabSafety">Lab Safety</A></LI><LI><A href="/Team:TU-Eindhoven/PublicSafety">Public and Environmental Safety</A></LI><LI><A href="/Team:TU-Eindhoven/SafetyiGEM">Biosafety Within iGEM</A></LI><LI id="tue-menu-society" class="dropdown"><A class="dropdown-toggle" data-toggle="dropdown" href="#">Society </A></LI><LI><A href="/Team:TU-Eindhoven/Outreach">Outreach</A></LI><LI><A href="/Team:TU-Eindhoven/Society">Human Practice</A></LI><LI id="tue-menu-notebook"><A href="/Team:TU-Eindhoven/Notebook">Notebook</A></LI></DIV></DIV></DIV></DIV><DIV class="tue-content container"><TABLE id="toc" class="toc"><TBODY><TR><TD><DIV id="toctitle"><H2>Contents</H2></DIV><UL><LI class="toclevel-1 tocsection-1"><A href="#Main_Results"><SPAN class="tocnumber">1</SPAN><SPAN class="toctext">Main Results</SPAN></A></LI><LI class="toclevel-2 tocsection-2"><A href="#Aerobic_Expression"><SPAN class="tocnumber">1.1</SPAN><SPAN class="toctext">Aerobic Expression</SPAN></A></LI><LI class="toclevel-2 tocsection-3"><A href="#CEST_Agent_Testing"><SPAN class="tocnumber">1.2</SPAN><SPAN class="toctext">CEST Agent Testing</SPAN></A></LI><LI class="toclevel-2 tocsection-4"><A href="#Anaerobic_FNR_Testing"><SPAN class="tocnumber">1.3</SPAN><SPAN class="toctext">Anaerobic FNR Testing</SPAN></A></LI><LI class="toclevel-2 tocsection-5"><A href="#General_Result"><SPAN class="tocnumber">1.4</SPAN><SPAN class="toctext">General Result</SPAN></A></LI></UL></TD></TR></TBODY></TABLE><H1><SPAN class="mw-headline" id="Main_Results">Main Results</SPAN></H1><H2><SPAN class="mw-headline" id="Aerobic_Expression"> Aerobic Expression </SPAN></H2><P>In the experiments for the aerobic expression of the proteins, we saw that we were able to produce a number of proteins correctly. The proteins 1ETF, 1PJN, 1G70 and EGFP were visibly produced and purified by means of their His-Tag and/or exclusion body extraction. The other proteins we had designed were not seen as clearly, many not all, after expression, however, for most of these proteins, we did end up seeing CEST contrast.  We can conclude that the following Biobricks were expressed most succesfully: <A href="http://parts.igem.org/Part:BBa_K1123014" class="external text" rel="nofollow">BBa_K11230014</A>, <A href="http://parts.igem.org/Part:BBa_K1123015" class="external text" rel="nofollow">BBa_K1123015</A>, <A href="http://parts.igem.org/Part:BBa_K1123016" class="external text" rel="nofollow">BBa_K1123016</A> and <A href="http://parts.igem.org/Part:BBa_K1123017" class="external text" rel="nofollow">BBa_K1123017</A>. For more detailed information and further results obtained during these experiments, see <A href="https://2013.igem.org/Team:TU-Eindhoven/CESTAgentTesting" class="external text" rel="nofollow">CEST Agent Testing</A>.
</P><H2><SPAN class="mw-headline" id="CEST_Agent_Testing"> CEST Agent Testing </SPAN></H2><P>To evaluate all the potential CEST contrast agents, MRI measurements were carried out and analyzed as described in <A href="/Team:TU-Eindhoven/MRIProcessing" title="Team:TU-Eindhoven/MRIProcessing"> MRI Data Processing</A>. The most promising agents seemed to be the lysine based contrast agents. All compounds that have a high lysine percentage expressed lysine based CEST contrast. The best distinguishable agent was <I>1PJN</I> (<A href="http://parts.igem.org/Part:BBa_K1123015" class="external text" rel="nofollow">BBa_K1123015</A>), based on the graph below ().
</P><DIV class="tue-float tue-float-left span12"><DIV class="tue-caption"><SPAN class="tue-caption-figure"><SPAN class="tue-refid">1PJNMRIPlot</SPAN></SPAN> <SPAN class="tue-caption-text">Contrast plots of the agent <I>1PJN</I>, for explanation see <A href="/wiki/index.php?title=Team:TU-Eindhoven/MRIProcessing_MRI_Data_Processing&amp;action=edit&amp;redlink=1" class="new" title="Team:TU-Eindhoven/MRIProcessing MRI Data Processing (page does not exist)">Team:TU-Eindhoven/MRIProcessing MRI Data Processing</A>.</SPAN></DIV></DIV><H2><SPAN class="mw-headline" id="Anaerobic_FNR_Testing"> Anaerobic FNR Testing </SPAN></H2><P>After analyzing the samples taken during anaerobically induced expression of EGFP, we can conclude that the FNR promoter is a functional Biobrick. This conclusion was made after viewing the understanding gels and noticing the increased intensity of the bands related to the EGFP protein.  
</P><DIV class="row"><DIV class="tue-float tue-float-left span6"><DIV class="tue-caption"><SPAN class="tue-caption-figure"><SPAN class="tue-refid">SDSgelXL1blue</SPAN></SPAN> <SPAN class="tue-caption-text">12% SDS gel with the bugbustered samples of the XL1-Blue anaerobic expressions of EGFP.</SPAN></DIV></DIV><DIV class="tue-float tue-float-right span6"><DIV class="tue-caption"><SPAN class="tue-caption-figure"><SPAN class="tue-refid">SDSgelXL1bluepur</SPAN></SPAN> <SPAN class="tue-caption-text">12% SDS gel with the purified samples of the XL1-Blue anaerobic expressions of EGFP</SPAN></DIV></DIV></DIV><P>To strengthen this argument a Western Blot was performed allowing us to bind antibodies directly to EGFP. By performing the necessary washing steps and staining the following blot membrane was found.
</P><DIV class="row"><DIV class="tue-float tue-float-left span9"><DIV class="tue-caption"><SPAN class="tue-caption-figure"><SPAN class="tue-refid">WesternBlot</SPAN></SPAN> <SPAN class="tue-caption-text">Western Blot performed on purified samples of EGFP expressed anaerobically. C- is a negative control, a purified sample of culture medium allowed to house EGFP expressing bacteria  in an aerobic environment. C+ is a positive control of EGFP bound to a CNA35 protein. The first 6 samples t1 to t6 were expressed anaerobically at 0% Oxygen whereas the second set of 6 samples t1 to t6 were expressed at 5% Oxygen</SPAN></DIV></DIV></DIV><P>In  it becomes clear that EGFP is being produced as only EGFP proteins will bind to the EGFP specific antibodies. In  we also note the disappearance of all other bands on the Western Blot.
</P><P>Furthermore we also performed fluorescence measurements of the samples taken at different time points during the anaerobically induced expression of EGFP. These can be viewed below. 
</P><DIV class="row"><DIV class="tue-float tue-float-left span6"><DIV class="tue-caption"><SPAN class="tue-caption-figure"><SPAN class="tue-refid">Fluorescencemeasurements</SPAN></SPAN> <SPAN class="tue-caption-text">Emission spectra of EGFP from the XL1-Blue anaerobic expression samples</SPAN></DIV></DIV><DIV class="tue-float tue-float-right span6"><DIV class="tue-caption"><SPAN class="tue-caption-figure"><SPAN class="tue-refid">Emissionpeaks</SPAN></SPAN> <SPAN class="tue-caption-text">Values of the peaks of the emission spectra of EGFP per sample</SPAN></DIV></DIV></DIV>
What becomes clear from the fluorescence measurements is that the amount of EGFP is indeed increasing in accordance with increases in the time. (Which also confirms that the low intensity bands seen in the gels above were in fact EGFP). These experiments resulted in the conclusion that we have two more functional Biobricks: <A href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K1123000" class="external text" rel="nofollow">BBa_K1123001</A> and <A href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K1123005" class="external text" rel="nofollow">BBa_K1123005</A>. 
To see detailed information and results, see <A href="https://2013.igem.org/Team:TU-Eindhoven/AnearobicTesting" class="external text" rel="nofollow">Anaerobic FNR Testing</A>.
<H2><SPAN class="mw-headline" id="General_Result"> General Result </SPAN></H2><P>As a general result of all the experiments, we have obtained a promising CEST contrast agent alongside a functional FNR promoter, which can be induced anaerobically at 37°C. When exposed to hypoxic conditions for longer periods of time we also notice an increase in the amount of protein being produced, as we would expect.   
Overall, we showed that all the separate mechanisms are working correctly and that a combined construct is still functional. This proof of concept is promising, but further experiments, such as <I>in vivo</I> experiments and experiments to ensure the killing mechanism works, need to be performed to say whether this could really be used for tumor targeting within the human body.
</P></DIV><DIV class="tue-gototop-sticky"><A href="#top" title="Go to the top of the page">Go to Top   </A></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2013.igem.org/Team:TU-Eindhoven/Results">http://2013.igem.org/Team:TU-Eindhoven/Results</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:TU-Eindhoven/Results" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:TU-Eindhoven/Results" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:TU-Eindhoven/Results&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:TU-Eindhoven/Results&amp;oldid=331946" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2013.igem.org:Privacy_policy" title="2013.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2013.igem.org:General_disclaimer" title="2013.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>